Sort   by:  
 Page size 
UnknownTherapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis.
Not available
S-EPMC3169557 | biostudies-literature
UnknownPhase I study of tirabrutinib (ONO-4059/GS-4059) in patients with relapsed or refractory B-cell malignancies in Japan.
Not available
S-EPMC6500982 | biostudies-literature
UnknownAnexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms.
Not available
S-EPMC5709104 | biostudies-literature
UnknownEffects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity.
Not available
S-EPMC2583320 | biostudies-literature
UnknownTwo-year outcomes of tirabrutinib monotherapy in Waldenstrom's macroglobulinemia.
Not available
S-EPMC9207369 | biostudies-literature
TranscriptomicsGene expression of ultra violet irradiation of silk worm Bombyx mori larvae
3 day of fifth instar larvae were treated with ultra-violet (UV) rays using UVL-56 (1350?W/cm2, UVP) for 6 and 12 hours (29.2 and 58.32 J/cm2). Since, larvae of each group rare on artificial diet for 24 hour and dissected fatbody. We examined gene expression profile in these groups. Gene expression ...
ORGANISM(S): Bombyx mori 
2015-02-26 | E-GEOD-55816 | biostudies-arrayexpress
TranscriptomicsIdentification of EP4 as a Potential Target for the Treatment of Castration-Resistant Prostate Cancer Using a Novel Xenograft Model
More effective therapeutic approaches for castration-resistant prostate cancer (CRPC) are urgently needed, thus reinforcing the need to understand how prostate tumors progress to castration resistance. We have established a novel mouse xenograft model of prostate cancer, KUCaP-2, which expresses the...
ORGANISM(S): Homo sapiens 
2010-06-08 | E-GEOD-21887 | biostudies-arrayexpress
UnknownDelivery of Hydrophobic Drugs to the Posterior Ocular Region by Gel-in-Water Nanoemulsion.
Not available
S-EPMC9123518 | biostudies-literature
TranscriptomicsBiopsies from metastatic Clear Cell Renal Carcinoma before or after treatment with nivolumab
Tumor core needle biopsies from kidney or metastatic sites obtained at trial enrollment i.e. Screen and/or at Cycle 2 Day 8 (i.e.Week 4) from metastatic clear cell RCC patients treated with 0.2mpk, 3mpk or 10mpk (as 2nd or further line of therapy; Arms A,B,C) or 10mpk (as first line therapy; Arm D) ...
ORGANISM(S): Homo sapiens 
2016-05-15 | E-MTAB-3218 | biostudies-arrayexpress
TranscriptomicsBlood RNA from metastatic Clear Cell Renal Carcinoma patients before or after treatment with nivolumab
Blood samples obtained at Cycle 1 Day 1, Cycle 1 Day 2 or at Cycle 2 Day 8 (i.e. before treatment, 24 hours after treatment or Week 4) from metastatic clear cell RCC patients treated with 0.2mpk, 3mpk or 10mpk (as 2nd or further line of therapy; Arms A,B,C) or 10mpk (as first line therapy; Arm D) of...
ORGANISM(S): Homo sapiens 
2016-05-15 | E-MTAB-3219 | biostudies-arrayexpress
Sort   by:  
 Page size